ClinicalTrials.gg

Xuanzhu Biopharmaceutical Co., Ltd. clinical trials

A subsidiary of Sihuan Pharmaceutical Holdings Group Ltd.

The registry lists 24 studies whose lead sponsor is Xuanzhu Biopharmaceutical Co., Ltd.. 11 are recruiting or about to start. Per ClinicalTrials.gov, last updated May 26, 2026.

What it is testing

The drugs Xuanzhu Biopharmaceutical Co., Ltd.’s studies test, most open studies first — 4 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Coming up

2 of Xuanzhu Biopharmaceutical Co., Ltd.’s studies under way reach primary completion within a year, 1 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. 1D
  3. J’27
  4. 1F
  5. M
  6. A
  7. M
  8. J
  9. J
  10. A
  11. S
  12. O
  13. N

Add all 2 to your calendar (.ics) → With an account.

All 24 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now1146%Not yet recruiting 8 · Recruiting 3
  • Under way, not recruiting28%
  • Completed28%
  • Status unknown or other938%

Phase

  • Phase 115
  • Phase 35
  • Phase 23
  • Phase 42

Where

Over the years

  1. 19
  2. 20
  3. 721
  4. 22
  5. 23
  6. 24
  7. 25
  8. 326

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

  • Xuanzhu Biopharmaceutical Co., Ltd.24 studies

Something wrong with this grouping? Tell us on the Sihuan Pharmaceutical Holdings Group Ltd. page.

Studies

Recruiting first, then most recently updated. Showing 24 of 24. All Sihuan Pharmaceutical Holdings Group Ltd. studies →